A study of a new ultrasound scan to check if breast lumps are safe or risky

ISRCTN ISRCTN11338253
DOI https://doi.org/10.1186/ISRCTN11338253
Submission date
08/09/2025
Registration date
17/09/2025
Last edited
16/09/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study is looking at a new way to help doctors decide whether a lump in the breast might be cancerous. Right now, ultrasound scans are commonly used, but they don’t always give a clear answer. The researchers are testing a technique called “elastography,” which measures how stiff the lump is. Stiffer lumps are more likely to be cancerous. The aim is to see if elastography can improve diagnosis and reduce unnecessary biopsies.

Who can participate?
Women who have been found to have a breast lump that looks uncertain (but not highly suspicious) on a regular ultrasound scan—specifically those classified as BI-RADS 3 or 4a—may be invited to take part.

What does the study involve?
If you agree to take part, a trained sonographer will perform an additional scan using elastography. This scan is painless and non-invasive. Afterwards, you’ll have a core needle biopsy, which is the standard way to check if a lump is cancerous. The results from the scans and biopsies will be compared, but the people doing each test won’t know the results of the other to keep things fair.

What are the possible benefits and risks of participating?
There’s no direct benefit to you, but your participation could help improve how breast lumps are diagnosed in the future. The elastography scan is safe and non-invasive. The biopsy is a routine procedure, but like any medical test, it carries small risks such as bruising or infection.

Where is the study run from?
Erbil breast center (Iraq)

When is the study starting and how long is it expected to run for?
July 2024 to July 2025

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Nasik Majeed, drnasik21@gmail.com

Contact information

Dr Nasik Majeed
Public, Scientific, Principal Investigator

40 m street beside Cihan Bank
Erbil
-
Iraq

ORCiD logoORCID ID 0000-0003-3350-657X
Phone +964 7504905284
Email drnasik21@gmail.com

Study information

Study designProspective diagnostic accuracy study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleDiagnostic Accuracy of Sound Touch Elastography Versus Conventional Ultrasound in BI-RADS 3 and 4a Breast Masses
Study objectivesThe objective of this study is to evaluate the role of sound touch elastography, quantification, and shear ratio in breast mass classification. It assesses whether incorporating them into ultrasound for BI-RADS 3 and 4a masses can improve category upgradation or down-gradation.
Ethics approval(s)

Approved 06/08/2025, Research Ethics Committee (College of medicine- Hawler medical university- Khanzad street, Erbil, -, Iraq; +964 7507791292; ruqaya.taher@hmu.edu.krd), ref: 11

Health condition(s) or problem(s) studiedPatients with breast masses, BIRADS 3 and 4
InterventionPatient eligibility verified, informed consent obtained, demographics and clinical history recorded, and clinical breast exam performed. Conventional ultrasound with BI-RADS assessment done, we selected BI RADS 3 and 4a breast masses for our study and further assessment by Sound Touch elastography for the mass and shell, recording quantitative metrics (Emax, Emean, STQ), and shear ratio (lesion-to-fat ).
The data saved and completed questionnairre form. (Total time for imaging session: ~30–60 minutes.)
If BI-RADS 4a: we arranged ultrasound-guided core-needle biopsy within 7 days. .
If BI-RADS 3: ultrasound-guided core-needle biopsy arranged for patients with positive family history of breast cancer, on surgeon's request, or on request of health-concious patients
The histopathology result (returned within 7–14 days) for the final diagnosis
Intervention typeProcedure/Surgery
Primary outcome measure1. Breast masses assessed using a single measurement of ultrasonography, as well as a separate singular measurement using elastography
2. Additional information collected through a questionnaire detailing the patient’s medical history
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date15/07/2024
Completion date25/07/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit17 Years
Upper age limit70 Years
SexFemale
Target number of participants184
Total final enrolment133
Key inclusion criteriaPatients with BIRADS 3 and 4 breast masses with sizes between 5-30 mm
Key exclusion criteria1. Masses less than 5 mm and larger than 30 mm
2. Refused biopsy
3. Pregnant or lactating women
4. Breast with implant or scar
5. Masses stable for more than one year
Date of first enrolment05/10/2024
Date of final enrolment10/07/2025

Locations

Countries of recruitment

  • Iraq

Study participating centre

Erbil breast center
40 m street beside Cihan Bank
Erbil
-
Iraq

Sponsor information

Hawler Medical University
University/education

College of Medicine, Hawler Medical University
Khanzad Street, Near Hawler Teaching Hospital
Erbil, Kurdistan Region
Erbil
P.O. Box 40/0112
Iraq

Phone +964 66 222 7275
Email medicine@hmu.edu.krd
Website https://www.hmu.edu.krd/colleges/college-of-medicine
ROR logo "ROR" https://ror.org/02a6g3h39

Funders

Funder type

Other

investigator initiated and Funded

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository, Available on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study will be stored in a publicly available repository (see study outputs)

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Dataset SAPP sav file 15/09/2025 No No
Dataset zip file of docx files. Questionnaires 15/09/2025 No No

Additional files

47965 DATA spss 133 cases.sav
SAPP sav file
47965 Raw data questionnaires.zip
zip file of docx files. Questionnaires

Editorial Notes

15/09/2025: Trial's existence confirmed by Hawler Medical University.